Researchers have developed a wireless, closed-loop system that uses electrocatalysis to manage "diabesity" — the combined condition of diabetes and obesity — without drugs, according to Science | AAAS. The work was published on Thursday, 22 October 2026.
The approach was picked up by several outlets. Scientific American described the device as an implant that "burns up excess blood sugar with electricity," while Mirage News reported that the tiny implant relies on a catalyst to lower blood sugar in diabetes treatment. Together, the coverage points to a small implanted device that acts on glucose directly rather than through medication.
The term "diabesity" reflects the overlap between type 2 diabetes and obesity, which frequently occur together. The system described in the reporting is "closed-loop," meaning it is designed to respond to the body's condition as part of a self-regulating cycle, and it operates wirelessly. The electrocatalytic element indicates that electrochemical reactions, aided by a catalyst, drive the effect on blood sugar.
Because the available reporting does not include the underlying study's full details, specifics such as the device's size, how long it was tested, and results in animal or human subjects have not been disclosed here. Those details would be found in the original paper in Science.
What to watch next: whether the team publishes fuller trial data and how the implant's long-term safety and performance compare with existing diabetes treatments.